SMART anti-IL-12 antibody (PDL BioPharma)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSMART anti-IL-12 antibody (PDL BioPharma)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionInterleukin-12 receptor inhibitors

TargetsInterleukin-12 receptor

Therapy Area/IndicationsInflammationAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPdl Biopharma Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPdl Biopharma Inc

Active IndicationsN/A

Inactive IndicationsInflammationAutoimmune Diseases

ATC CodeN/A